Nutrition Industry Executive Awarded Runner-Up for NIE 2021 Award Category: Excipients/Non-Actives/Delivery Systems to Stratum Nutrition's VitaSperse
ncarol.com/10140723

CARTHAGE, Mo. - ncarol.com -- Stratum Nutrition®, (a business of ESM Technologies), and 3i Solutions, are pleased to announce VitaSperse® Technology has been awarded Runner-Up for the NIE 2021 Award: Excipients/Non-Actives/Delivery Systems. VitaSperse is a unique microemulsion technology that disperses water-insoluble ingredients into water-based liquid applications.

Steve Peters, Director of Product Development at 3i Solutions, said, "Everyone at 3i Solutions is honored and excited that our innovative VitaSperse technology has been selected for an NIE award. Being able to deliver water-insoluble nutrients in the VitaSperse form allows formulators to create water-based products that deliver stable nutrients with enhanced absorption.* We feel the benefits of VitaSperse will help our customers bring superior and healthier products to the public."

All VitaSperse ingredients start with reverse osmosis water. Only food-grade ingredients are used to create VitaSperse formulations. Lecithin and non-ionic surfactants are the main building blocks of the VitaSperse microemulsion. Then, a preservative system is added, depending upon use and preference. VitaSperse encapsulates nutritional actives, providing a unique layer of protection. Next, the VitaSperse formulation undergoes a proprietary process that results in a uniform dispersion of actives encapsulated by lipids. This dispersion allows oil-soluble ingredients to stay suspended in water indefinitely.

More on ncarol.com

• PADT Earns Prestigious 2025 Americas Customer Loyalty Award from Ansys, Part of Synopsys
• Florida Keys Visitors Can Save 15 Percent With KeysCaribbean's Advanced Booking Discount
• Sleep Basil Unveils Revamped Natural Latex Mattress Collection Page for Cooler, Cleaner, Better-Aligned Sleep
• Conexwest Delivers Custom Shipping Container MRI Lab, Saving California Hospital an Estimated $9 Million in Renovation Costs
• DASH Carolina RDU Sets the Pace in 2025 with Record-Breaking Sales and Team Excellence

Micah Osborne, President of Stratum Nutrition, said, "I am very happy to see VitaSperse gaining recognition for the great delivery technology that it is. VitaSperse is the magic behind many great products already out on the market. This technology allows us to offer our customers a way to create new product forms, resulting in improved formulations with better performance characteristics of their finished products. I look forward to seeing more great things from our technology partners at 3i Solutions."

For more information about Stratum Nutrition and its branded ingredients, please email Info@StratumNutrition.com or visit their website, https://www.stratumnutrition.com/.

###

About Stratum Nutrition

Stratum Nutrition®, a business of ESM Technologies, LLC, is a trusted ingredient innovator supplying unique, world-class nutrition ingredients and delivery technologies to product formulators for human and pet health. Stratum offers a portfolio of research-supported ingredients that stand out in their respective health categories as being progressive, safe, and effective, including NEM® brand eggshell membrane, LBiome™ Lactobacillus LB postbiotic, Ahiflower®, BLIS K12™, BLIS M18™, Nataxtin™ astaxanthin, Curcumin 95, and ESC® brand eggshell calcium. These trusted ingredients are relied upon by consumers internationally. Visit www.stratumnutrition.com for more information.

More on ncarol.com

• Wespor Business Launches AI Voice and Chat Agents to Help Triangle Small Businesses Capture Missed Leads
• America's Boating Club Ushers in New Board at Change of Watch
• FDA Meeting Indicates a pivotal development that could redefine the treatment landscape for suicidal depression via NRx Pharmaceuticals: $NRXP
• $2.7 Million 2025 Revenue; All Time Record Sales Growth; 6 Profitable Quarters for Homebuilding Industry: Innovative Designs (Stock Symbol: IVDN)
• CCHR: Decades of Warnings, Persistent Inaction; Studies Raise New Alarms on Psychiatric Drug Safety